公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers | Liu C.-C.; Wang Y.-H.; Chuang E.Y.; Tsai M.-H.; YA-HUI CHUANG ; Lin C.-L.; CHUN-JEN LIU ; Hsiao B.-Y.; Lin S.-M.; Liu L.-Y.; MING-WHEI YU | Molecular Carcinogenesis | 7 | 5 | |
2013 | IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients | Hsu C.-S.; SHIH-JER HSU ; Liu W.-L.; CHI-LING CHEN ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 10 | 8 | |
2022 | Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines | Liu, Chieh; Shih, Yi Fen; CHUN-JEN LIU | International Journal of Molecular Sciences | 3 | 3 | |
2022 | The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan | Lin C.-L.; Tai C.-M.; Huang J.-F.; CHUN-JEN LIU ; Chen H.-F.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Wang C.-C.; Weng S.-H.; TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 2 | 2 | |
2013 | Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression | Huang C.-J.; Wu C.-F.; Lan C.-Y.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU ; Liu H.-F.; MING-WHEI YU | PLoS ONE | 14 | 15 | |
2012 | Impact of hepatitis B virus infection on metabolic profiles and modifying factors | Hsu C.-S.; CHEN-HUA LIU ; Wang C.-C.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 60 | 54 | |
2017 | Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up | Chen H.-Y.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Yang W.-T.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 12 | 9 | |
2022 | Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B | Hsueh, Rei-Chi; Wu, Wan-Jung; Lin, Chih-Lin; CHUN-JEN LIU ; Huang, Yi-Wen; Hu, Jui-Ting; Wu, Chih-Feng; Sung, Feng-Yu; Liu, Wen-Jie; MING-WHEI YU | Journal of Hepatocellular Carcinoma | | 9 | |
2022 | Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR) | Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; SHIH-JER HSU ; JIA-HORNG KAO ; CHUN-JEN LIU ; CHEN-HUA LIU ; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. | Clinical Gastroenterology and Hepatology | 14 | 12 | |
2010 | Implications of hepatitis B virus genomic variations on treatment outcomes | TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Current Pharmacogenomics and Personalized Medicine | 5 | 0 | |
2016 | Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis | Yang H.-I.; TAI-CHUNG TSENG ; Liu J.; Lee M.-H.; CHUN-JEN LIU ; TUNG-HUNG SU ; Batrla-Utermann R.; Chan H.L.Y.; JIA-HORNG KAO ; Chen C.-J. | Clinical Gastroenterology and Hepatology | 25 | 22 | |
2010 | Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection | Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; TAI-CHUNG TSENG ; Chen C.-H.; Su W.-C.; CHUN-JEN LIU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 14 | 16 | |
2002 | Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan | MING-WHEI YU ; Chang H.-C.; PEI-JER CHEN ; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. | International Journal of Epidemiology | 27 | 27 | |
2015 | Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort study | YI-WEN HUANG ; Wang T.-C.; Yang S.-S.; Lin S.-Y.; Fu S.-C.; Hu J.-T.; CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Alimentary Pharmacology and Therapeutics | 23 | 23 | |
2017 | Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study | MING-WHEI YU ; Lin C.-L.; CHUN-JEN LIU ; Yang S.-H.; Tseng Y.-L.; Wu C.-F. | Gastroenterology | 129 | 117 | |
2005 | Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C | CHUN-JEN LIU ; YUNG-MING JENG ; PEI-JER CHEN ; Lai M.-Y; HUNG-CHIH YANG ; Huang W.-L; JIA-HORNG KAO ; DING-SHINN CHEN | Antiviral Therapy | 34 | 32 | |
2012 | Influences of tobacco and alcohol use on hepatocellular carcinoma survival | WEI-LIANG SHIH ; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; CHUN-JEN LIU ; Lin C.-L.; MING-WHEI YU | International Journal of Cancer | 49 | 44 | |
2011 | Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohort | Chao L.-T.; Wu C.-F.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU ; Huang C.-J.; KEH-SUNG TSAI ; MING-WHEI YU | Carcinogenesis | 52 | 45 | |
2006 | Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study | CHUN-JEN LIU ; Lai M.-Y.; Chao Y.-C.; Liao L.-Y.; Yang S.-S.; Hsiao T.-J.; Hsieh T.-Y.; Lin C.-L.; Hu J.-T.; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 41 | 35 | |
2007 | Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges | CHEN-HUA LIU ; CHUN-JEN LIU ; JIA-HORNG KAO | Nephrology | 2 | 7 | |